# Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients

> **NCT01548495** · — · UNKNOWN · sponsor: **yair levy** · enrollment: 100 (estimated)

## Conditions studied

- Myelodysplatic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01548495
- **Lead sponsor:** yair levy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01548495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01548495, "Autoantibodies Against Human Recombinant Erythropoietin in Myelodysplatic Syndrome Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01548495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*